BRIEF published on 07/23/2024 at 17:57, 1 month 28 days ago Hardman & Co Research on H&T Group: Global Pawnbroking Market Analysis Regulation Global Market H&T Group Pawnbroking Historical Context
PRESS RELEASE published on 07/23/2024 at 17:52, 1 month 28 days ago Hardman & Co Research on H&T Group (HAT): Pawnbroking: the global perspective for H&T Hardman & Co Research delves into the global perspective of pawnbroking for H&T Group, highlighting market size, cultural adoption, and regulatory environment Hardman & Co Research Pawnbroking Global Perspective Market Size Regulatory Environment
BRIEF published on 07/23/2024 at 11:57, 1 month 28 days ago Hardman & Co discute de la stratégie de valeur ajoutée d'Apax Global Alpha Investissement L'allocation Du Capital Apax Global Alpha Stratégie Des Trésors Cachés Valeur Du Portefeuille
BRIEF published on 07/23/2024 at 11:57, 1 month 28 days ago Hardman & Co Discusses Apax Global Alpha's Value Addition Strategy Investment Capital Allocation Portfolio Value Apax Global Alpha Hidden Gems Strategy
PRESS RELEASE published on 07/23/2024 at 11:52, 1 month 28 days ago Q&A on Apax Global Alpha (APAX): CM day presentation – How Apax adds value Hardman & Co Research discusses Apax Global Alpha's value addition in recent CM day presentation with analyst Mark Thomas, highlighting new strategies and future benefits for investors Hardman & Co Research Investment Companies Apax Global Alpha CM Day Presentation Value Added
BRIEF published on 07/12/2024 at 13:47, 2 months 8 days ago Les résultats de Duke Capital pour l'exercice 2024 montrent des flux de trésorerie records Recherche Hardman & Co DUC Capitale Résultats De L'exercice 2024 Enregistrer Les Flux De Trésorerie
BRIEF published on 07/12/2024 at 13:47, 2 months 8 days ago Duke Capital's FY'24 Results Show Record Cashflows Hardman & Co Research DUKE Capital FY'24 Results Record Cashflows
PRESS RELEASE published on 07/12/2024 at 13:42, 2 months 8 days ago Hardman & Co Research on Duke Capital (DUKE): FY’24 results: record cashflows Hardman & Co Research highlights Duke Capital's FY'24 results, showcasing record cashflows driven by various returns strategies. Learn more in the full report Hardman & Co Research DUKE Capital Equity-type Returns FY'24 Results Record Cashflows
BRIEF published on 07/11/2024 at 11:43, 2 months 9 days ago La stratégie de croissance défensive d'ICG Enterprise Trust mise en avant par Hardman & Co Capital-investissement L'allocation Du Capital Fiducie D'entreprise ICG Stratégie De Croissance Défensive Approche D'investissement
BRIEF published on 07/11/2024 at 11:43, 2 months 9 days ago ICG Enterprise Trust's Defensive Growth Strategy Highlighted by Hardman & Co Private Equity ICG Enterprise Trust Capital Allocation Defensive Growth Strategy Investment Approach
Published on 09/20/2024 at 23:40, 5 hours 20 minutes ago Integrated BioPharma Reports Results for Its Quarter and Fiscal Year Ended June 30, 2024
Published on 09/20/2024 at 23:30, 5 hours 30 minutes ago Final Bell Holdings International Ltd. Announces Sale of Final Bell Corp.
Published on 09/20/2024 at 22:30, 6 hours 30 minutes ago Electric Metals Announces Changes to its Board of Directors
Published on 09/20/2024 at 22:15, 6 hours 45 minutes ago Torq Clarifies Finder’s Warrant Exercise Price of $0.10 Financing
Published on 09/20/2024 at 22:58, 6 hours 1 minute ago Freelance.com: Mise à disposition du Document d’Enregistrement Universel 2023
Published on 09/20/2024 at 21:00, 8 hours ago Aurubis celebrates ribbon-cutting at the first multimetal recycling plant in the United States
Published on 09/20/2024 at 20:14, 8 hours 45 minutes ago EQS-Adhoc: GRAMMER AG sells TMD Group in North America
Published on 09/20/2024 at 19:50, 9 hours 10 minutes ago BRAIN Biotech AG concludes major pharma compound transaction valued up to EUR 128.88 million from its BioIncubator
Published on 09/20/2024 at 19:47, 9 hours 13 minutes ago EQS-Adhoc: BRAIN Biotech AG concludes royalty monetization deal for up to EUR 128.88 million on investigational pharma compound deucrictibant with Royalty Pharma
Published on 09/20/2024 at 17:40, 11 hours 20 minutes ago Availability of the 2024 Half-Year Financial Report
Published on 09/20/2024 at 17:40, 11 hours 20 minutes ago Mise à disposition du Rapport Financier Semestriel 2024